Drug Profile
Research programme: gene silencing therapeutics - GeneSegues
Alternative Names: GS-10Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GeneSegues
- Class Nucleic acids
- Mechanism of Action Protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 16 Apr 2016 Pharmacodynamics data from a preclinical study in Cancer presented at the 107th Annual Meeting of the American Association for Cancer Research (AACR-2016)
- 19 Nov 2009 Pharmacodynamics data from a preclinical trial in cancer presented at the 21st AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2009)